vs
Liberty Global Ltd.（LBTYA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Liberty Global Ltd.的季度营收约是Royalty Pharma plc的2.0倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -237.0%，领先271.4%），Liberty Global Ltd.同比增速更快（187.2% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -20.4%）
自由全球有限公司是一家英荷美合资的跨国电信企业，注册地位于百慕大，在伦敦、阿姆斯特丹和丹佛均设有总部。公司旗下拥有英国自由全球控股有限公司、荷兰自由全球有限公司及美国自由全球公司三大主体，其中英国主体为上市实体。企业由自由媒体国际业务部与UnitedGlobalCom于2005年合并成立，在全球电信服务领域拥有深厚的行业积累。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LBTYA vs RPRX — 直观对比
营收规模更大
LBTYA
是对方的2.0倍
$622.0M
营收增速更快
LBTYA
高出182.4%
4.8%
净利率更高
RPRX
高出271.4%
-237.0%
两年增速更快
RPRX
近两年复合增速
-20.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $-2.9B | $214.2M |
| 毛利率 | 66.8% | — |
| 营业利润率 | -8.6% | 62.4% |
| 净利率 | -237.0% | 34.4% |
| 营收同比 | 187.2% | 4.8% |
| 净利润同比 | -230.0% | 2.9% |
| 每股收益（稀释后） | $-8.66 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LBTYARPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.3B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $-1.4B | $593.6M | ||
| Q3 24 | $1.9B | $564.7M | ||
| Q2 24 | $1.9B | $537.3M | ||
| Q1 24 | $1.9B | $568.0M |
净利润LBTYARPRX
| Q4 25 | $-2.9B | $214.2M | ||
| Q3 25 | $-90.7M | $288.2M | ||
| Q2 25 | $-2.8B | $30.2M | ||
| Q1 25 | $-1.3B | $238.3M | ||
| Q4 24 | $2.2B | $208.2M | ||
| Q3 24 | $-1.4B | $544.0M | ||
| Q2 24 | $268.1M | $102.0M | ||
| Q1 24 | $510.0M | $4.8M |
毛利率LBTYARPRX
| Q4 25 | 66.8% | — | ||
| Q3 25 | 67.5% | — | ||
| Q2 25 | 63.3% | — | ||
| Q1 25 | 65.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 69.4% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | 65.4% | — |
营业利润率LBTYARPRX
| Q4 25 | -8.6% | 62.4% | ||
| Q3 25 | -0.7% | 70.1% | ||
| Q2 25 | 2.3% | 36.3% | ||
| Q1 25 | 5.2% | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 1.0% | 50.2% | ||
| Q1 24 | 1.2% | -13.0% |
净利率LBTYARPRX
| Q4 25 | -237.0% | 34.4% | ||
| Q3 25 | -7.5% | 47.3% | ||
| Q2 25 | -220.1% | 5.2% | ||
| Q1 25 | -114.2% | 41.9% | ||
| Q4 24 | -158.9% | 35.1% | ||
| Q3 24 | -74.1% | 96.3% | ||
| Q2 24 | 14.3% | 19.0% | ||
| Q1 24 | 26.2% | 0.8% |
每股收益（稀释后）LBTYARPRX
| Q4 25 | $-8.66 | $0.49 | ||
| Q3 25 | $-0.27 | $0.67 | ||
| Q2 25 | $-8.09 | $0.07 | ||
| Q1 25 | $-3.84 | $0.55 | ||
| Q4 24 | $6.15 | $0.46 | ||
| Q3 24 | $-3.95 | $1.21 | ||
| Q2 24 | $0.71 | $0.23 | ||
| Q1 24 | $1.32 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2B | $618.7M |
| 总债务越低越好 | $7.8B | $9.0B |
| 股东权益账面价值 | $9.7B | $9.7B |
| 总资产 | $22.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.80× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LBTYARPRX
| Q4 25 | $2.2B | $618.7M | ||
| Q3 25 | $1.7B | $938.9M | ||
| Q2 25 | $3.1B | $631.9M | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | $2.2B | $929.0M | ||
| Q3 24 | $3.3B | $950.1M | ||
| Q2 24 | $3.2B | $1.8B | ||
| Q1 24 | $2.8B | $843.0M |
总债务LBTYARPRX
| Q4 25 | $7.8B | $9.0B | ||
| Q3 25 | $7.8B | $8.9B | ||
| Q2 25 | $7.8B | $8.0B | ||
| Q1 25 | $8.2B | $7.6B | ||
| Q4 24 | $8.2B | $7.6B | ||
| Q3 24 | $14.9B | $7.6B | ||
| Q2 24 | $14.7B | $7.6B | ||
| Q1 24 | $14.8B | $6.1B |
股东权益LBTYARPRX
| Q4 25 | $9.7B | $9.7B | ||
| Q3 25 | $12.7B | $9.6B | ||
| Q2 25 | $13.0B | $9.5B | ||
| Q1 25 | $12.6B | $9.8B | ||
| Q4 24 | $12.4B | $10.3B | ||
| Q3 24 | $18.7B | $10.3B | ||
| Q2 24 | $18.3B | $9.8B | ||
| Q1 24 | $18.4B | $9.9B |
总资产LBTYARPRX
| Q4 25 | $22.6B | $19.6B | ||
| Q3 25 | $25.4B | $19.3B | ||
| Q2 25 | $27.2B | $18.3B | ||
| Q1 25 | $26.0B | $17.6B | ||
| Q4 24 | $25.4B | $18.2B | ||
| Q3 24 | $41.8B | $18.0B | ||
| Q2 24 | $40.8B | $17.7B | ||
| Q1 24 | $40.6B | $16.1B |
负债/权益比LBTYARPRX
| Q4 25 | 0.80× | 0.92× | ||
| Q3 25 | 0.61× | 0.93× | ||
| Q2 25 | 0.60× | 0.84× | ||
| Q1 25 | 0.65× | 0.78× | ||
| Q4 24 | 0.66× | 0.74× | ||
| Q3 24 | 0.80× | 0.74× | ||
| Q2 24 | 0.80× | 0.78× | ||
| Q1 24 | 0.80× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $630.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $193.3M | — |
| 自由现金流率自由现金流/营收 | 15.7% | — |
| 资本支出强度资本支出/营收 | 35.5% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-132.0M | — |
8季度趋势，按日历期对齐
经营现金流LBTYARPRX
| Q4 25 | $630.9M | $827.1M | ||
| Q3 25 | $301.8M | $702.6M | ||
| Q2 25 | $149.2M | $364.0M | ||
| Q1 25 | $129.2M | $596.1M | ||
| Q4 24 | $791.6M | $742.5M | ||
| Q3 24 | $449.5M | $703.6M | ||
| Q2 24 | $546.1M | $658.2M | ||
| Q1 24 | $245.7M | $664.6M |
自由现金流LBTYARPRX
| Q4 25 | $193.3M | — | ||
| Q3 25 | $-41.1M | — | ||
| Q2 25 | $-170.1M | — | ||
| Q1 25 | $-114.1M | — | ||
| Q4 24 | $712.9M | — | ||
| Q3 24 | $102.4M | — | ||
| Q2 24 | $256.8M | — | ||
| Q1 24 | $-105.1M | — |
自由现金流率LBTYARPRX
| Q4 25 | 15.7% | — | ||
| Q3 25 | -3.4% | — | ||
| Q2 25 | -13.4% | — | ||
| Q1 25 | -9.7% | — | ||
| Q4 24 | -50.5% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | -5.4% | — |
资本支出强度LBTYARPRX
| Q4 25 | 35.5% | — | ||
| Q3 25 | 28.4% | — | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | 20.8% | — | ||
| Q4 24 | -5.6% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 15.4% | — | ||
| Q1 24 | 18.0% | — |
现金转化率LBTYARPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 0.35× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 2.04× | 6.45× | ||
| Q1 24 | 0.48× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LBTYA
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
